Table 1 Correlation of DLGAP1-AS2 expression with clinicopathologic parameters in 64 NSCLC patients
Clinicopathologic parameter | Total (n = 64) | DLGAP1-AS2 expression level | P-value | |
|---|---|---|---|---|
Lower (n = 33) | Higher (n = 31) | |||
Age (years) | 0.321 | |||
≤ 57 | 36 | 15 | 21 | |
> 57 | 28 | 16 | 12 | |
Sex | 0.756 | |||
Male | 39 | 22 | 17 | |
Female | 25 | 12 | 13 | |
AJCC stage | 0.360 | |||
I/II | 26 | 18 | 8 | |
III/IV | 38 | 10 | 28 | |
Histological grade | 0.839 | |||
Well and middle | 34 | 16 | 18 | |
Low | 30 | 15 | 15 | |
Tumor diameter | 0.004** | |||
T ≤ 5 cm | 31 | 21 | 10 | |
T > 5 cm | 33 | 9 | 24 | |
Lymph node | 0.213 | |||
Negative | 34 | 25 | 9 | |
Positive | 30 | 8 | 22 | |